Repligen (RGEN) EBITDA Margin (2009 - 2026)
Repligen (RGEN) posted EBITDA Margin of 18.37% for Q2 2026, down 2.52 percentage points from 20.89% a year earlier and down 2.26 percentage points from the prior quarter.
Repligen (RGEN) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Repligen was 20.47%, up 10.57 percentage points year-over-year; for FY2025, it was 20.39%, up 12.49 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -9.06 percentage points (FY2020 to FY2025).
- In prior years, Repligen's EBITDA Margin was 7.90% in FY2024 (-10.87 pp), 18.77% in FY2023 (-15.85 pp), 34.62% in FY2022 (+2.22 pp) and 32.40% in FY2021 (+2.95 pp).
- The Q2 2026 figure stands as the lowest quarterly EBITDA Margin since Q1 2025.
- On a year-over-year basis, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of +1.85 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2025, with a gain of 29.73 percentage points; the weakest was Q4 2024, with a drop of 25.39 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 20.63% (Q1 2026), 21.27% (Q4 2025) and 21.73% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.44 Bn | 236.08 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 187.98 Bn | 162.45 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 163.91 Bn | 143.58 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 153.75 Bn | 134.17 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 131.67 Bn | 97.80 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 117.84 Bn | 104.03 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.27 Bn | 59.95 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 61.69 Bn | 45.00 Bn | 1.35 Bn | 20.05% |
| 9 | Medline | 51.94 Bn | 49.07 Bn | 1.93 Bn | 9.79% |
| 10 | Repligen | 9.51 Bn | 6.29 Bn | 110.99 Mn | -4.78% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -4.78% |
| Jun 30, 2026 | 18.37% |
| Mar 31, 2026 | 20.63% |
| Dec 31, 2025 | 21.27% |
| Sep 30, 2025 | 19.73% |
| Jun 30, 2025 | 20.89% |
| Mar 31, 2025 | 17.33% |
| Dec 31, 2024 | -8.46% |
| Sep 30, 2024 | 8.71% |
| Jun 30, 2024 | 16.60% |
| Mar 31, 2024 | 15.97% |
| Dec 31, 2023 | 16.93% |
| Sep 30, 2023 | 17.69% |
| Jun 30, 2023 | 22.52% |
| Mar 31, 2023 | 17.95% |
| Dec 31, 2022 | 34.09% |
| Sep 30, 2022 | 32.77% |
| Jun 30, 2022 | 36.47% |
| Mar 31, 2022 | 35.02% |
| Dec 31, 2021 | 27.69% |
Repligen EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RGEN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();